Clinical Trial Update: Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and relative bioavailability study of bococizumab (PF-04950615; RN316) when administered to abdomen, thigh, or upper arm in adults with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Bococizumab (bococizumab)

Snippet

Sponsor: Pfizer | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED | Results posted: 2019-05-31